Tilidine

This classification denotes an opioid analgesic, narcotic, and cyclohexanecarboxylic acid with the molecular formula C17H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GY33N31E9Y, chemically known as 3-cyclohexene-1-carboxylic acid, 2-(dimethylamino)-1-phenyl-, ethyl ester, trans-(+-)- but generally known as tilidine, which bears US NIH Compound Identifier 30131. European Medicines Agency schedules Tilidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11051MIG. World Health Organization schedules tilidine in its Anatomical Therapeutic Chemical (ATC) Classification. TILIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tilidine under HS 29224400 and SITC 51465. As of Q4 2014, TILIDINE remains the US FDA Preferred Term for this commodity. SMILES: O(C(=O)C1(C(N(C)C)C=CCC1)C1CCCCC1)CC.